Graft-versus-host disease

2 papers1 finding

Humans1
Animals1

Associations

1

Intrasplenic thymus regeneration

downin mice1

1 study

Intrasplenic thymus regeneration lowers the risk of graft-versus-host disease in mice.
Animalsrelative to intramuscular implantation
Intrasplenic Thymus Organogenesis from Injectable Tissue Fragments Restores Functional T-Cell Immunity
Advanced science (Weinheim, Baden-Wurttemberg, Germany)25 Aug 2026

More on Intrasplenic thymus regeneration

Trial sponsors

Astellas Pharma
Company3 trialsPhase 439 people
Novartis Pharmaceuticals Corporation
Company1 trialPhase 4279 people
Incyte
Company3 trialsPhase 3973 people
Mesoblast
Company1 trialPhase 3260 people
Chia Tai Tianqing Pharmaceutical Group
Company1 trialPhase 3182 people
Baxalta now part of Shire
Company1 trialPhase 3105 people
Chimeric Therapies
Company1 trialPhase 2/3
Swedish Orphan Biovitrum
Company1 trialPhase 2155 people

Latest

2 in 12 months

Advanced Science25 Aug

Intrasplenic Thymus Organogenesis from Injectable Tissue Fragments Restores Functional T-Cell Immunity

Experiments in miceBlood and immune system

JAMA Dermatology12 Aug

Risk Stratification Models for Cutaneous Malignant Neoplasms After Blood or Marrow Transplant

Cohort study of 3,448 peopleBiomarkers